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It is generally acknowledged that the age of antibiotics could come to an end,
due to their widespread, and inappropriate use. Particularly for chronic wounds
alternatives are being thought. Antimicrobial Photodynamic Therapy (APDT) is a potential
candidate, and while approved for some indications, such as periodontitis, chronic
sinusitis and other niche indications, its use in chronic wounds is not established.
To further facilitate the development of APDT in chronic wounds we present an
easy to use animal model exhibiting the key hallmarks of chronic wounds, based on
full-thickness skin wounds paired with an optically transparent cover. The moisture-
retaining wound exhibited rapid expansion of pathogen colonies up to 8 days while
not jeopardizing the host survival. Use of two bioluminescent pathogens; methicillin
resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa permits real
time monitoring of the pathogens. The murine model was employed to evaluate the
performance of four different photosensitizers as mediators in Photodynamic Therapy.
While all four photosensitizers, Rose Bengal, porphyrin TMPyP, New Methylene Blue,
and TLD1411 demonstrated good to excellent antimicrobial efficacy in planktonic
solutions at 1 to 50 µM concentrations, whereas in in vivo the growth delay was
limited with 24–48 h delay in pathogen expansion for MRSA, and we noticed longer
growth suppression of P. aeruginosa with TLD1411 mediated Photodynamic Therapy.
The murine model will enable developing new strategies for enhancement of APDT for
chronic wound infections.
Keywords: photodynamic therapy, topical infection, chronic wounds, bioluminescence, Pseudomonas
aeruginosa, methicillin resistant Staphylococcus aureus
INTRODUCTION
Chronic wounds, generally comprising diabetic foot ulcers, pressure ulcers, venous leg ulcers,
burn wounds, and wounds “older than 3 months of age” (Kirketerp-Møller et al., 2011) are a
worldwide healthcare issue. They are causing a cycle of pain, anxiety and reduced quality of life
for the individual patient, and present a considerable cost to the health care providers and patient
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(Dowsett, 2015). It is estimated that chronic wound therapies
account for 2–4% of the total health system expenses, including
material cost, nurse time, and hospitalization, that estimate is
excluding the indirect costs such as loss of productivity and
out-of-pocket expenses for patients (Sen et al., 2009). Over
90% of chronic wounds contain bacteria and fungi acquired
from the skin, oral mucosa, enteric tract, or the environment
(Kucera et al., 2014), which prevent tissue remodeling and
healing. These bacteria can form a multispecies biofilm,
which is often held responsible for the further development
of an infection (Kucera et al., 2014). Infections commonly
benefit from a priori compromised immune functions due
to other diseases and/or their treatments, resulting in the
lack of particular immune system components such as B
cells, T cells, antibodies, neutrophils, damage to immune
organs etc. Secondary immunodeficiency is often exploited
by various microorganisms leading to grievous infections.
Immunodeficiency is a well-established risk factor for cancer
patients receiving chemotherapy (Pardoll, 2012; Khan et al.,
2015).
Any break in the barrier function of the skin and other
epithelial layers, predisposes an individual to infections (Schreier
and Chatterjee, 2015). One of the major issues in controlling
the healing initiation versus infection is sustaining the moisture
balance in the tissue. Swollen and suppurative wounds provide
perfect growth conditions for anaerobic and aerobic pathogens
colonization and expansion thereof (Kirketerp-Møller et al.,
2011), whereas a dehydrated wound surface can delay the healing
process. Hence, while preserving a moist wound environment
is advisable (Lilge et al., 2000) concurrent eradication and
suppression of pathogenic microorganisms are highly desirable.
A delay or failure in the treatment of moist wounds can
lead to bacterial colonization progression and can cause the
development of systemic infection.
Currently, there are some therapies to control infected
wounds. The most classical – antibiotic therapy – starts to be
inefficient as multidrug-resistant strains keep spreading and
continue to expand unchecked. The increase in multidrug
resistant strains to conventional antibacterial therapies has
prompted the development of alternatives antimicrobial
therapies, particularly for hard-to-heal wounds (Troxler et al.,
2006). Negative pressure wound therapy promotes wound
healing by applying a vacuum through a special dressing.
It increases the granulation tissue formation and the local
blood flow and enhances the bacterial clearance (Ene et al.,
2015). Wound dressing saturated with silver, iodine or other
antimicrobial agents can help the body achieve the ideal moist,
warm healing conditions and simultaneously protect the wound
from environmental exposure during this process (Murphy and
Evans, 2012). Numerous plants are used in folk medicine against
various diseases, albeit the exact mechanism of their action
remains largely unknown, although antimicrobial properties of
this phytotherapy have been investigated (Halcon and Milkus,
2004; Joubert et al., 2008; Kumar et al., 2008) and many of
them are considered biofilm disruption agents. Combination
of ethnopharmacology and antibiotic therapy could provide an
effective bactericidal tool for the treatment of various bacterial
and yeast infections (Taraszkiewicz et al., 2013). Low-Level Laser
Therapy (LLLT) seems to exert possibly exploitable antimicrobial
effects, especially against Pseudomonas aeruginosa caused
infections, whereas it appears to be less or ineffective against
other bacterial strains (Nussbaum et al., 2003, 2009).
To address the local nature of chronically infected wounds
Antimicrobial Photodynamic Therapy (APDT) provides appe-
aling properties. In APDT, a chemical compound (photo-
sensitizer) absorbs light photons with sufficient quantum energy
resulting in its electronic excited state, from which energy can
be transferred to biomolecules or to molecular oxygen. The
latter leads to the generation of Reactive Oxygen Species (ROS)
or singlet oxygen formation, which can cause cell damage and
microorganism’s death as recently reported by Taraszkiewicz et al.
(2013) in in vitro studies of APDT. Localization of the therapy
is achieved by two different mechanisms; first the confinement
of the activation light to the clinical target area and second the
difference in temporal photosensitizer association and uptake by
bacteria versus host cells.
While efficacy of APDT has been demonstrated in various
planktonic in vitro studies, transition to in vivo studies showed
variable results, with some pre-clinical models showing good
efficacy, whereas the majority of the studies demonstrated a poor
translation of the APDT efficacy in vivo.
Typically, to quantify a therapy’s efficacy, based on the
eradicated bacterial number, one group of hosts need to be
sacrificed immediately after treatment and a second group need
to be kept up to 50 h to determine the microbiota survival
fraction. Blood samples can also be taken to analyze possible
bacteremia development. Hamblin et al. (2003) and Wong et al.
(2005) created full thickness excisional wounds, by using surgical
scissors and forceps. Small wounds (8–9 mm × 12.5 mm) were
infected with bioluminescent bacterial strains P. aeruginosa (106)
or Vibrio vulnificus (106), allowing observation of wound healing
and infection development within individual animals. As wounds
remain uncovered, mice had to be kept separate to prevent
opportunistic contaminations between animals. Zolfaghari et al.
(2009) used two wound models: excisional and superficial. In
the first case, shaved and depilated skin was pinched by sterile
forceps and a 6 mm circular area (28 mm2) was cut down till the
subcutaneous areolar tissue using scissors. In the second model a
25 mm2 square shaped wound was created by scarification using
a 27G needle. Both skin preparations were inoculated with 108
CFUml−1 MRSA cells on the wounds. To assess the effectiveness
of the therapy mice were sacrificed upon treatment and the
number of surviving bacteria was quantified following incubation
on agar plates.
The ideal pre-clinical model of hard-to-heal wounds should
be based on an immunocompromised host, thus permitting
systematic infection. However, that model requires weeks
to be established and carries significant risk of sepsis and
survival failure. Also the use of immunocompromised animals
can dramatically increase the cost of the research. Minimal
animal number, wound drying, dressing changes causing wound
oxygenation variations, unnecessary animal pain, or large surface
area damage are some of the important factors to be considered
during the in vivo experimental design stage.
Frontiers in Microbiology | www.frontiersin.org 2 August 2016 | Volume 7 | Article 1258
fmicb-07-01258 August 6, 2016 Time: 16:24 # 3
Fila et al. Wound Model for Antibacterial PDT
Here we demonstrate a TegadermTM based topical infection
model for antimicrobial PDT as local antimicrobial therapy, and
demonstrate its utility by testing Rose Bengal (RB), porphyrin
TMPyP New Methylene Blue (NMB), or TLD1411 mediated
APDT.
By the use of strong skin adhering, vapor and light trans-
mitting dressings (Lilge et al., 2000), a moist wound environment
is maintained providing perfect condition for wound healing
as well as bacterial growth and the development of infection.
Dressings can be kept for several days, isolating wounds
from environmental- and cross-contaminations, permitting
co-housing of animals thus reducing their stress level. Of
additional advantage is the use of bioluminescent bacterial
strains permitting non-invasive longitudinal monitoring of the
therapeutic efficacy in each animal, reducing the number of
animals required to achieve statistical significance. Moreover,
from an animal care point, the possibility to decrease the wound
size as well as provide opportunistic infection prevention will
promote better tissue reconstruction.
To demonstrate the utility of the murine model, we validated
the efficacy of 4 different photosensitizers RB, porphyrin TMPyP,
NMB, and TLD1411 as APDT mediators in planktonic solution,
demonstrated the need for a covered wound for maintaining an
ongoing infection and finally demonstrated the ability to quantify
APDT outcome in this murine model, in vivo as time delay until
pathogen regrowth is noted.
MATERIALS AND METHODS
Animals
All procedures were approved by the Animal Care Committee
(ACC) of University Health Network, Toronto, ON, Canada
(protocol number AUP 3303.2). FVB/N mice of both sexes,
originally obtained from Xenogen Corporation – Alameda,
CA but tested negative for the luciferase gene were used.
Animals were housed in 12-h day/night cycles, at 20◦C room
temperature, granulated food, and water were provided ad
libitum.
In total 51 mice were required for this study and randomly
assigned to one of 6 groups: (i) non-infected mice (n = 3) to
establish the duration of normal wound healing. Groups (ii)
to (iv) represent infected wounds without APDT comprising:
(ii) Tegaderm dressing, (iii) no dressing, and (iv) removal of
dressing at the end of day 2 from established infection to
evaluate the need for the transparent dressing to maintain the
infection control throughout the observation period. For these
groups n = 3 animals were used for each of the two bacterial
strains employed here. The APDT treatment groups v) comprised
n ≥ 3 × 2 bacterial strains for each of the four photosensitizers
were tested. Group (vi) evaluated APDT efficacy versus potential
LLLT effects employing a light only group for both bacterial
strains.
Infected Wound Induction Procedure
The day before wound establishment, the animals were
anesthetized by isoflurane using 4% for induction and 1.5 to 2.5%
for maintenance delivered via nose cone. Their dorsal surface hair
was shaved and remaining hair removed with depilatory lotion.
The next day, after repeating anesthesia a pinch of skin in the
center of the shaved area (0.5 cm to 1 cm above the ilium bones)
was held by tweezers and top layer of the skin is cut off to cause 5
to 6 mm diameter wound.
Immediately after cutting the skin the wound area was
inoculated with10 µl of PBS containing 107 CFU bacteria using a
pipette tip. For mice in groups ii to vi TegadermTM was applied
immediately as per group assignment and kept for the assigned
time.
Dressing
1.5 cm by 1.5 cm squares of TegadermTM (Transparent Film Roll
3MTM) were cut and applied to the wound area. According to
commercial specification, the dressing is breathable permitting
oxygen in and moisture vapor out thus allowing the skin
to function normally. TegadermTM is transparent and no
light attenuation needs to be considered (Lilge et al., 2000).
TegadermTM studies have demonstrated positive effect on wound
healing process in patients. Patients reported less pain during
dressing changes, as well as more comfort with daily usage
(Ravenscroft et al., 2006).
Bacterial Strains
Two bioluminescence pathogens: Methicillin Resistant Staphy-
lococcus aureus (MRSA) strain (XEN) (Caliper, City, State)
and Pseudomonas aeruginosa (PAK) were used. PAK is a wild
type, commonly studied P. aeruginosa strain containing and
expressing a full complement of virulence factors. The strain
has luxAB inserted into its chromosome thereby exhibiting
bioluminescent properties (Ramphal et al., 2008).
Bacteria were incubated for 18 h at 37◦C in fresh LB liquid
broth. After overnight incubation, tubes were vortexed and
the volume adjusted to obtain 107 CFUml−1. Next, bacteria
were centrifuged and re-suspended in 20 µl sterile PBS. To
control the concentration of bacteria a serial dilutions of the
utilized suspension was prepared and inoculated on fresh LB
agar plate followed by incubation for 18 h at 37◦C. Colonies
were counted on the next day to determine the original bacteria
concentration.
Light Source
A custom built LED light source emitting λ = 525 ± 15 nm
(manufactured by Theralase Inc. Toronto, ON, Canada) was
employed and the output was focused on the wound area. The
light source of non-coherent light, delivering an irradiance of
50 mWcm−2 to the wound surface as verified by a NIST traceable
optical power meter (Nova Power Meter, Ophir Photonics). The
light source was used previously for in vivo phototherapy studies
and did not cause thermal effects (Arenas et al., 2013; Fong et al.,
2015). The light was administrated continuously for 37 min,
resulting in a radiant exposure of 100 Jcm−2.
Photosensitizers
Four Photosensitizers were evaluated for their APDT efficacy
in vitro and in vivo: RB, NMB, TMPyP, and TLC1411. All
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photosensitizers were excited at 525 nm to minimize APDT
efficacy differences due to variations in the wavelength dependent
penetration depth into the moist infected wounds. Comparing
the efficacy between the photosensitizers is thus only a
function between their respective molar extinction coefficients at
525 nm.
Rose Bengal (4,5,6,7-tetrachloro-2′,4′,5′,7′-tetraiodofluores-
cein) (Sigma–Aldrich) is a sodium salt used in medicine
as an eye drops to stain damaged conjunctival and corneal
cells (Ervin et al., 2010). Maximum absorption wavelength
λmax = 548 nm and the molar extinction coefficient at 525 nm
is 3653 molL−1cm−1. The singlet oxygen quantum yield was
reported as 0.74 (Lee and Rodgers, 1987).
New Methylene Blue is a thiazine class compound used as a
dye or antimicrobial agent (Ragas et al., 2013) with an absorption
maximum at λmax = 590 nm, a molar extinction coefficient at
525 nm of 471 molL−1cm−1 and a singlet oxygen quantum yield
of 0.66 ± 0.04 in air equilibrated acetonitrile (Ronzani et al.,
2013).
TMPyP [5,10,15,20-Tetrakis(1-methyl-4-pyridinio) porp-
hyrin tetra(p-toluenesulfonate)] (Sigma–Aldrich) is a positively
charged, two-photon dye, that can bind to DNA in cell cultures
and affect the cell viability. Its one photon peak absorption
wavelength λmax = 421 nm. Its molar extinction coefficient
at 525 nm is 1306 molL−1cm−1, and it has a singlet oxygen
quantum yield of 0.74 (Reddi et al., 2002).
TLD1411 is a Ru(II) coordination complex of the form [Ru(2,2′
-bipyridine)2(2-(2′,2′′:5′′,2′′′-terthiophene)-imidazo[4,5-f][1,10]
phenanthroline)]2+, originally synthesized by Dr. McFarland
at Arcadia University and provided by Sigma Aldrich Fine
Chemicals (Milwaukee, WI, USA). Its use as an APDT agent has
been previously described (Arenas et al., 2013). Its absorption
maximum is 430 nm in water and its molar extinction coefficient
at 525 nm is 831 molL−1cm−1. The singlet oxygen quantum
yield was reported as >0.9 in complete media (Shi et al.,
2015).
Figure 1 shows the wavelength resolved molar extinction
coefficient of these four photosensitizers.
FIGURE 1 | Absorption coefficient of 10 µM solutions of Rose Bengal
(blue), New Methylene blue (NMB) (green), TMPyP (orange), and
TLD1411 (red) as function of wavelength. The 525 nm Antimicrobial
Photodynamic Therapy (APDT) activation wavelength is indicated.
All photosensitizers were freshly prepared prior to the
procedure as 1 mM stock solution in water, and diluted to the
proper test concentration before being added to the bacterial
culture.
In vitro Experiments
All procedures were performed using sterile 96-well plates.
Bacteria were diluted in fresh Luria–Bertani (LB) broth
to a final planktonic concentration of 3·107 CFUml−1.
The photosensitizer solution was added at predetermined
concentrations ranging from 1 µM to 150 µM equivalent
to a final concentration of 2·108 to 3·1010 PS molecules per
bacterium. 100 µl of the PS solution was pipetted into wells
followed immediately by photoactivation using the light source
described above. Non-irradiated sample served as negative
controls. Upon completion of light administration, samples were
serial diluted and inoculated on fresh LB agar plates. A positive
result required more than 3 magnitudes of log10 per CFUml−1
reduction in these planktonic conditions. PDT irradiation used a
96-diode laser array delivering 100 Jcm−2 total radiant exposure.
In vivo Experiments
All procedures of wound establishment and bacterial inoculation
were executed as described above. 30 min post bacterial
inoculation 30 µl of the 500 µM photosensitizer solutions was
injected under the dressing by Hamilton syringe and allowed to
spread over the wound for an estimated final concentration of
∼2·109 photosensitizer molecules per bacterium. Photoactivation
was initiated after 30 min of wait period.
Bioluminescence Imaging
Images were collected using the IVIS Spectrum imaging system
(Caliper Life Sciences, Hopkinton, MA, USA). For imaging,
mice were anesthetized using isoflurane, as described above.
Mice were imaged at specific time points: immediately after
bacteria inoculation, prior to and after PS injection, prior to
and after light administration, then every 10 min post APDT
therapy up to 2–3 h, followed then daily up to 5th day or the
endpoint determined in the protocols. APDT efficacy for bacterial
inactivation was measured by loss of bioluminescent signal,
defined as average radiance [hυs−1cm−2sr−1] and subjective
evaluation of the wound’s appearance. The bioluminescence
(BLI) radiance was determined by selecting equal size of
the region-of-interest (ROI) directly over the wound and
between the two shoulders blade to determine the cameras dark
counts.
RESULTS
Infection Development in Open versus
Covered Wounds
In TegadermTM covered wounds an increase in bioluminescent
signal was observed after inoculation with either PAK or XEN
strain, starting from day 0 up to 3rd (PAK) or 4th (XEN) day
of experiment. Then, a plateau phase was reached lasting up to
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FIGURE 2 | Comparison of BLI signal from open (red) and TegadermTM dressed (blue) wounds for (Left) XEN and (Right) PAK.
8th day after wound inoculation with bacteria (Figure 2). On
the contrary, in wounds left open from the beginning as well as
those where the TegadermTM was removed after 48 h, a reversal
of the initial increase in BLI radiance was observed. The wound’s
appearance was dry after 2 days, and a pink appearance was
retained.
The appearance of the TegadermTM dressed wound changed
from the clear raw appearance to yellowish dense mucus on day
2 and 3, whereas they appeared yellow for the remainder of the
observed duration. Often the wound expanded and the infection
bulged the dressing outward as shown in Figure 3, for PAK
inoculated wounds.
FIGURE 3 | Top shows the visual appearance of the wound over the
5-day observation period for a covered; non-treated wounds (A),
covered, treated with Rose Bengal, Pseudomonas aeruginosa infected
wound (B); covered; treated with TLD1411; Staphylococcus aureus
infected wounds (C); uncovered, non-treated; infected wounds (D). The
spread of the infection is clearly visible in (A and B), while (C) showed delay of
infection. Left upper corners: Shown are examples of BLI signal as function of
time over the first 5 days following wound generation and infection.
APDT in Planktonic Solutions
There was no significant dark toxicity of the photosensitizers
toward the investigated bacteria within the concentration range
studied (up to 500µM), except for TLD1411 at>10µM for XEN.
Whereas, upon illumination all studied photosensitizers showed
activity against PAK, and TLD1411 also against XEN bacteria;
see Figures 4 and 5, for PAK and XEN results, respectively.
The susceptibilities of bacteria to APDT mediated by one of
the four sensitizers, was tested at increasing concentration of
photosensitizers at three radiant-exposures ranging from 50 to
150 Jcm−2.
Rose Bengal showed positive effect toward PAK with 75 µM
concentration and 50 Jcm−2 radiant exposure. Increasing light
dose up to 150 Jcm−2 resulted in a decreasing RB concentration
required to elicit a response. 50 µM of RB and 150 Jcm−2
decreased below the level of detection CFU ml−1 units up to 6
log10 (Figure 4A). APDT response reciprocity between radiant
exposure and RB concentration breaks down for concentration
above 50 µM presumably due to self-shielding within the 1 cm
path length in the planktonic solutions used in these experiments,
see below.
New Methylene Blue showed least antimicrobial activity
against PAK. Only 10 µM concentration showed reduction
of 3 log10 of survival cells when 100 Jcm−2 were applied,
whereas 50 Jcm−2 failed to elicit a beneficial APDT response,
both presumably due to self-shielding. At higher doses the
photosensitizer showed no significant impact on efficacy. Unlike
Rose Bengal, NMB had no dose-dependent efficacy, thus no
significant difference in PAK inactivation from 10 to 150 µM
when exposed the solution to 150 Jcm−2 (Figure 4B).
Porphyrin TMPyP reached a positive anti-bacterial effect
against PAK when 150 or 100 Jcm−2 were administered.
Increasing the light exposure led to a higher inactivation effect at
lower PS doses and even 10 µM concentration exhibit significant
CFU ml−1 reduction. The combination of 75 µM concentration
and 150 Jcm−2 of green light resulted in 6 log10 eradication of
PAK (Figure 4C). As for NMB 50 Jcm−2 did not initiate sufficient
PAK inactivation again due to self-shielding within the 1 cm
path length cuvette. Self-shielding also caused loss of reciprocity
between light and PS doses.
TLD1411 was tested only for 100 Jcm−2 against PAK, so more
than 6 log10 was achieved at the lowest concentration of 1 µM
(Figure 4D) effectively reaching sterilization levels.
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FIGURE 4 | Antimicrobial Photodynamic Therapy inactivation in planktonic solutions for PAK with (A) Rose Bengal, (B) NMB, (C) TMPyP, and
(D) TLD1411. The radiant exposure used is indicated as blue squares = 50 Jcm−2, red triangles = 100 Jcm−2, and green circles = 150 Jcm−2. The black dotted
line with rhombus in (D) indicates dark toxicity.
FIGURE 5 | Antimicrobial Photodynamic Therapy inactivation in
planktonic solutions for XEN mediated by TLD1411. The employed
radiant exposure is indicated as black dotted line with rhombus = 0 Jcm−2,
red triangles = 100 Jcm−2.
Only TLD 1411 was tested for its activity against XEN in these
studies, and similar to PAK, 6 log10 inactivation was achieved
with the lowest concentration of 1µM (Figure 3). However, while
no significant dark toxicity against PAK was observed, TLD1411
showed significant dark toxicity,∼3 log10, at 10 µM against XEN
as noted already above.
Table 1 shows the critical concentration required to achieve 3
log10 and 6 log10 reduction in bacterial cell count for the highest
radiant exposure tested at 525 nm.
In vivo APDT in Infected Wounds
Unlike for in vitro planktonic cultures, the in vivo response
was much more moderate, with none of the photosensitizers
achieving sterilization of the wound equivalent to a 6 log10
TABLE 1 | Phototoxic sensitizer concentrations.
Photosensitizer PAK XEN
3 log10 6 log10 3 log10 6 log10
Rose Bengal 10 µM 50 µM N/A N/A
NMB 10 µM >150 µM N/A N/A
TMPyP 10 µM 75 µM N/A N/A
TLD1411 1 µM 10 µM <1 µM <1 µM
reduction. In fact, not even clearing at 3 log10 was attainable based
on BLI radiance measurements, see Figure 6.
As there was a variation in the group average BLI radiance for
PAK studies, the BLI signal was normalized at t = 0 just prior to
PS administration, permitting comparison of the APDT effects.
Untreated wounds with expanding bacterial counts reached
bioluminescence signal saturation at the first day. The two
principal reasons for this saturation effect are increased
infection thickness reabsorbing the bioluminescence photons and
increased light scattering from the wound further confining the
BLI radiance to the infection.
Rose Bengal mediated APDT resulted in the least BLI radiance
reduction,∼ one order of magnitude, or∼ 3.2 pathogen division
times, presenting limited benefit to wound management. NMB
had the highest BLI radiance reduction following APDT (∼ two
orders of magnitude); however, the BLI radiance regain was
faster than in untreated wound suggesting that the radiance loss
was due to biochemical luminescence quenching or bleaching
rather than bacterial inactivation. TMPyP had the 2nd best
APDT induced BLI radiance reduction, whereas post APDT
signal gains were comparable to untreated wounds suggesting
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FIGURE 6 | In vivo APDT bioluminescence for PAK in an untreated control (solid black), Rose Bengal (blue), NMB (green), TMPyP (orange), and
TLD1411 (red). The concentration of either PS was ∼2·109 molecules per bacterium.
true PAK inactivation or destruction by APDT. TLD1411 showed
signs of dark toxicity prior to PDT with accelerated BLI
radiance loss during PDT. BLI radiance recovery over the first
2 h was slower and accelerated over the next 22 h, reaching
BLI radiance increase rate comparable to untreated control
wounds.
Nevertheless, it should be noted that APDT mediated by either
photosensitizer resulted in a lower BLI radiance intensity than
non-treated control at 120 min, demonstrating the ability to delay
PAK infection progression by APDT of induced wounds, see
Figure 6.
The temporal evaluation of the XEN associated BLI in
untreated controls and TLD1411 mediated APDT is shown
in Figure 7, whereby untreated wounds reached BLI signal
saturation at 2 days post infection. The TLD1411 concentration
per XEN bacterium is estimated at∼2·107 and photo-irradiation
showed a continuous decrease in BLI radiance up to 90 min
post PDT (120 min time point). The regain of BLI radiance was
not significant until day 4, followed by a signal increase rate
comparable to the untreated control.
Group vi, included for evaluation of APDT efficacy versus
potential LLLT stimulatory effects due to light irradiation with
both bacterial strains were identical to group ii (non-treated,
infected wounds covered by Tegaderm). Bioluminescence
radiance signal increased for 2 days, reaching 108 and
106 hυs−1cm−2sr−1 of average normalized radiance for PAK and
XEN, respectively, and remained constant for the remainder of
the observation period (data not shown). Hence, LLLT does not
appear to be a confounder to PAK or XEN survival at 525 nm.
DISCUSSION
While various infected wound models have been published, there
is still a need for an applicable model mimicking the clinical
features of the disease, with short implementation time and
efficient translation of the study results into clinical practice.
Lee et al. (2011) created a large wound (1.5 by 2.5 cm)
by tape-stripping and sandpaper based removing of stratum
corneum and inoculating a bacterial suspension containing
∼1010 CFUml−1 S. aureus cells. Biopsies were collected at
specific time points to monitor wound healing and host cell
growth. Mice were kept in individual cages to prevent cross
contamination, affecting overall well-being of the animal by
causing stress. Saito et al. (2012) exposed dorsal skin to 90◦C
to induce burn injury up to 20% of the total body surface
area and then inoculated with 108 CFU of P. aeruginosa. The
model mimics large, festering wounds and can cause high pain
and stress levels. Application of an occlusive dressing to avoid
cross contamination is favorable in this model. Similar wounds
were established by Hashimoto et al. (2012), where preheated
steel was applied to the dorsal surface. Large burned areas (6–
6.5 cm2) were immediately infected using 108 P. aeruginosa
cells.
The murine model of an infected wound presented here is
robust and spontaneous bacterial clearing was not observed in
the TegadermTM covered wounds, thus it presents a favorable
environment for testing APDT efficacy in vivo. The wound cover
allows for oxygen and water vapor across the barrier and does not
impede light penetration either for BLI, APDT, or LLLT (Lilge
et al., 2000). It provides constant growth environment for both
PAK and XEN, as demonstrated in Figures 2 and 3, but prevents
opportunistic and environmental wound cross-contamination.
Several mice can be housed in the same cage reducing stress
levels during the experiment. Wounds, which were not covered
or intentionally uncovered, dried out rapidly and infections were
controlled without intervention either by the murine immune
system or simple dying of the bacterium in an unfavorable
environment possibly leading to an overestimation of the APDT
efficacy.
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FIGURE 7 | In vivo modulation of the XEN bioluminescence in an untreated control (solid black) and by TLD1411 mediated APDT (red).
Here the model was only utilized in the acute stage of
infection, so sufficiently long to open the possibility of resilience
against APDT, but insufficient to generate a deep infection,
particularly because the pO2 in chronically infected wounds has
been reported to be 30% to 90% lower than in healthy tissue
(Schreml et al., 2010). The latter may require photosensitizers
exploiting both type I and II APDT mechanisms (Fong et al.,
2015; Shi et al., 2015).
However, the combination of BLI together with consistent
growth environment allows testing various APDT protocols
including the number of retreatment frequencies and extending
the infection control.
As the APDT activation wavelength impacts the penetration
depth in the in vivo model, the most common wavelength of
525 nm was selected. However, the varying molar extinction
coefficient of these 4 photosensitizers led to self-shielding and
possibly with that reason limited efficacy in planktonic solution
for RB and NMB was observed. Selecting different concentrations
to match the molar extinction coefficient would impact on the
number of photosensitizers per bacterium, whereas selecting
different wavelength to match the molar extinction coefficient at
constant concentration would affect the light distribution in the
tissue and hence by diffuse reflected light also the photon density
at the tissue surface.
At time of APDT light treatment in vivo the target must
be considered 2D with minimum full-thickness wounds and
no observable presence of blood in an infected area. Hence,
comparing the efficacy using this animal model system is valid
purely on tissue optics consideration.
Nevertheless, the added attenuation of PS in in vivo condition
needs to be considered, particularly when comparing PS efficacy
in APDT. The worst-case impact on APDT radiance exposure
on the target can be estimated based on the solution volume
(30 µl) over the 6 mm diameter wound, which would result
in an ∼1 mm layer large compared to the diffusion distance
of the ROS. As the PS acts also as a 525 nm light filter prior
to the pathogens on the tissue surface, the resulting optical
densities are RB = 1.83, NMB = 0.235, TMPyP = 0.653,
and TLD1411 = 0.4155, respectively. In particular, for RB the
high concentration employed in conjunction with the high
molar extinction coefficient eventually caused a reduction of
the radiant exposure at the microbes to 1.48 Jcm−2. Similarly,
the worst-case radiant exposures for the other photosensitizers
would be NMB = 58.2 Jcm−2, TMPyP = 22.2 Jcm−2, and
TLD1411 = 38.4 Jcm−2, respectively. However, the solution
was rapidly absorbed into the tissue and the filter effect by the
photosensitizer had a lesser impact on the sensitizer specific
APDT efficacy differences.
Conversely, trying to achieve a comparable OD in the tissue
to eliminate effect of self-shielding as a confounding factor.
There is a need for either adjustment of the photosensitizer’s
concentration affecting the ratio of photosensitizing molecules
per bacterium or selecting particular wavelength for each
photosensitizer so that the molar extinction coefficients are the
same, which in turn would impact the photon distribution in the
tissue. Hence, our approach of using constant wavelength and
radiant exposures in the sensitizer was compared.
To maintain reasonable penetration of the activated light
into the tissue, the presence of oxy- or deoxy-hemoglobin needs
to be considered as their absorption coefficients for 525 nm
are > 102 cm−1 and the penetration depth would be limited
to < 100 µm (Jacques, 2013). Hence, the model can only be
valid for wounds free of blood or scab. When treating burns a
longer absorption wavelength is required for NMB or mixture of
Ru(II) containing photosensitizer with carrying molecules, such
as transferrin, which notably increases their molar extinction
coefficient in the 600 to 800 nm range (Kaspler et al., 2016). Care
must be taken regarding possible LLLT effects at these longer
wavelength (Nussbaum et al., 2003).
A radiant exposure of 150 Jcm−2 can be achieved in 12.5 min
according to the guidelines for safe irradiation of the skin, and the
duration is also clinically acceptable. However, the experiments
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showed that for optimal efficacy of the therapy, a maximum
irradiance of 50 mWcm−2 should not be exceeded allowing
sufficient oxygen diffusion throughout the TegadermTM wound
cover. So care must be taken as possible photosensitizer reuptake
into mammalian host cells, particular cells associated with the
immune system needs to be considered when the irradiation
times need to be extended significantly.
The efficacy of various photosensitizers against bacteria in
planktonic solutions have been previously published for RB
(Melo et al., 2011) and TMPyP (Cassidy et al., 2010) reporting
concentration of 10 µmol/L (6 log of killing) and 250 µg/L (4 log
of killing), respectively.
All photosensitizers have displayed good to excellent efficacy
in bacterial inactivation for planktonic solutions particularly
for PAK where 3 of 4 reached 6 log10 inactivation which is
considered as sterilization state and the other photosensitizer
(NMB) achieved at least 3 log10 of inactivation for 150 Jcm−2.
The efficacy limits for RB and TMPyP are probably an artifact
due to their high molar extinction coefficient and the high
concentration used, which prevented effective illumination
of the planktonic solution over the 1 cm sample depth.
Radiant exposure with a much lower absorption coefficient
of NMB compared to RB, its limited efficacy cannot be
attributed to self-shielding. Additionally, as the photosensitizers
have comparable singlet oxygen quantum yield one needs
to conclude that NMB does not associate well with PAK.
TLD1411 appears to present higher efficacy compared to other
photosensitizers with a concentration less than 10 µM being
sufficient for transient PAK sterilization at 100 Jcm−2. This
may be explained by the ability of these ruthenium complexes
to lead to DNA cleavage (Mari et al., 2014; Shi et al.,
2015).
The high efficacy of these PSs in vitro is poorly translated
into the in vivo applications, as previously noted (Amin et al.,
2016). The reason for this efficacy loss can be explained by host
factors as well as bacterial burden and the virulence of individual
strains as previously noted (Hamblin et al., 2003) and reflects a
more challenging environment also for the treatment of human
superficial infections.
One caveat to these experiments is the small number (n= 4–5)
employed for the different study groups. While this sample size
is too small to allow statistical analysis of the results between
photosensitizers, it is large enough to demonstrate an APDT
effect and the report time line for BLI signal delay and time to
signal saturation.
While only up to a 1.5 log10 reduction in BLI associated
radiance was detected by PS mediated APDT in vivo, it may
still be of clinical use. Based on the BLI radiance expression of
the PAK and XEN growth curve, pre and post light exposure,
it becomes evident that for certain protocols and conditions
APDT treated wounds do not reach the BLI radiance intensity
of the unexposed control for at least 24 h in case of PAK
mediated infection and more than 4 days for XEN mediated
ones. Despite the lack of complete response in wound sterilization
this additional time increases the period to early onset of risk
for local or systemic infection, thus providing the possibility
to perform wound culture and antibiotic sensitivity testing,
as about 90% of blood and other cultures are detected and
identified within 48 h (Cockerill et al., 2004). Peptide nucleic
acid fluorescence in situ hybridization (PNA FISH) methods are
currently used for direct identification of selected Staphylococcus,
Enterococcus, Klebsiella, and Candida species in less than 2 h
(Shepard et al., 2008). While a 1 to 2 h delay for PCA
determination of loss or the presence of genes encoding antibiotic
resistance are available and appear reasonable, PCA will not
describe functional protein and may be misleading, hence,
generally antibiotic susceptibility testing commonly requires 1
to 3 days and hence a general infection control for 24 to 72 h is
desirable.
CONCLUSION
Our murine model of consistent local wound infection with
Staphylococcus aureus (MRSA) and P. aeruginosa was similar to
chronic wounds, without spontaneous clearing due to wound
drying. The progress of the infection can be monitored real-
time for bioluminescent bacteria, thus permitting the rapid
evaluation of APDT agents and treatment protocols in vivo under
physiologically relevant conditions for bacterial growth.
The in vivo evaluation of antimicrobial effect of photo-
sensitizers responded less effectively compared to what were
seen in vitro, an observation also reported by others; however,
the potentially significant clinical reduction of the bacterial load
remains apparently feasible, causing delay in full activation of
inflammatory response and hence reducing the risk of developing
sepsis.
The presented murine model is a suitable platform to evaluate
the feasibility and safety of repeated cycles of PDT, based on
clearance time of photosensitizer from host mammalian cells.
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